Nimesh A. Patel, MD, discusses compounded low-dose atropine and SYD-101 ahead of an October 30 FDA advisory committee meeting ...
At Retina Society 2026, Emily Eton, MD, discusses a 10-center study finding similar exudate control in Coats disease and ...
Christina Y. Weng, MD, MBA, FASRS, highlights findings showing statin use reduced PVR risk by 25% in a propensity-matched ...
Three residents were honored for their leadership, education and research, and patient care contributions in ophthalmology, ...
Charles Wykoff, MD, PhD, reviews LUGANO safety and treatment burden data, including a 42% injection reduction with vorolanib ...
Subretinal drusenoid deposits (SDDs) in age-related macular degeneration may flag severe aortic stenosis that increases ...
Patient enrollment is complete in the the ASTRA phase 3 study AURN001 to treat corneal edema associated with corneal ...
At Retina Society 2026, Eileen Hwang, MD, PhD, discusses a meta-analysis finding a 1.78 times higher retinal detachment rate ...
Concurrent exudative disease, early intervention, and a rare masquerader complicate the classic picture of geographic atrophy ...
Breazzano, MD, FACS, shares findings from a TriNetX real-world database analysis on how HIV co-infection influences RPR ...
The phase 2 ArMaDa results showed that one subretinal injection of medium-dose OCU410, an investigational adeno-associated ...
Jesse L. Berry, MD, discusses prospective data on aqueous humor liquid biopsy in retinoblastoma and explains how molecular markers from the aqueous are beginning to guide recurrence risk, treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results